A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma

Journal of Hepatology

Volumn 49, Issue 6, 2008, Pages 1055-1061

  de Lima, Vicência M R ^a   Oliveira, Claudia P M S ^a   Alves, Venancio A F ^a   Chammas, Maria Cristina ^a   Oliveira, Ellen Pierre ^a   Stefano, José Tadeu ^a   de Mello, Evandro Sobroza ^a   Cerri, Giovanni Guido ^a   Carrilho, Flair José ^a   Caldwell, Stephen H ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Animal model; Cirrhosis; Fatty liver; Hepatocellular carcinoma; NAFLD; NASH

Indexed keywords

CYTOKERATIN 19; DRINKING WATER; FAT DROPLET;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; ECHOGRAPHY; ENDOPLASMIC RETICULUM; EXPERIMENTAL MODEL; FATTY LIVER; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LIPID DIET; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; MICROSCOPY; NONALCOHOLIC FATTY LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; SPRAGUE DAWLEY RAT; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CHOLINE DEFICIENCY; DIETARY FATS; DISEASE MODELS, ANIMAL; FATTY LIVER; HEPATOCYTES; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; LIVER NEOPLASMS; MICROSCOPY, ELECTRON, TRANSMISSION; RATS; RATS, SPRAGUE-DAWLEY;

EID: 55749106570     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.07.024     Document Type: Article

References (62)

1. Bosch F.X., Ribes J., Diaz M., and Cleries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 (2004) S5-S16
2. Bruix J., and Sherman M. Management of hepatocellular cancer (AASLD practice guideline). Hepatology 42 (2005) 1208-1236
3. Fattovich G., Stroffolini T., Zagni I., and Donato F. Hepatocellular cancer in cirrhosis: incidence and risk factors. Gastroenterology 127 (2004) S35-S50
4. El-Serag H.B., and Mason H.C. Rising incidence of hepatocellular carcinoma in the Unites States. N Engl J Med 19 (1999) 221-229
5. Kim W.R., Gores G.J., Benson J.T., Therneau T.M., and Melton L.J. Mortality and hospital utilization for hepatocellular cancer in the United States. Gastroenterology 129 (2005) 486-493
6. Caldwell S.H., Oliveira C.P.M.S., Lima V.M.R., and Park S.H. In: Bataller R., and Caballeri{dotless}́a J. (Eds). Nonalcoholic steatohepatitis (NASH) (2007), Permanyer Publications
7. Moller H., Mellemgaard A., Lindvig K., and Olsen J. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 30A (1994) 344-350
8. Calle E.E., Rodriguez C., Walker-Thurmond K., and Thun M.J. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348 (2003) 1625-1638
9. Nair S., Mason A., Eason J., Loss G., and Perrillo R.P. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?. Hepatology 36 (2002) 150-155
10. El-Serag H.B., Richardson P.A., and Everhart J.E. The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans. Am J Gastroenterol 96 (2001) 2462-2467
11. Lagiou P., Kuper H., Stuver S.O., Tzonou A., Trichopoulos D., and Adami H.-O. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst 92 (2000) 1096-1099
12. Wideroff L., Gridley G., Mellemkjaer L., Chow W.H., Linet M., Keehn S., et al. Cancer incidence in a population based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst 89 (1997) 1360-1365
13. Powell E.E., Jonsson J.R., and Clouston A.D. Steatosis: co-factor in other liver diseases. Hepatology 42 (2005) 5-13
14. Powell E.E., Ali A., Clouston A.D., Dixon J.L., Lincoln D.J., Purdie D.M., et al. Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology 129 (2005) 1937-1943
15. Leandro G., Mangia A., Hui J., Fabris P., Rubbia-Brandt L., Colloredo G., et al. HCV meta-analysis (on) individual patients' data study group. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 130 (2006) 1636-1642
16. Pekow J.R., Bhan A.K., Zheng H., and Chung R.T. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 109 (2007) 2490-2496
17. Tanaka A., Uegaki S., Kurihara H., Aida K., Mikami M., Nagashima I., et al. Hepatic steatosis as a possible risk factor for the development of hepatocellular carcinoma after eradication of hepatitis C virus with antiviral therapy in patients with chronic hepatitis C. World J Gastroenterol 13 (2007) 5180-5187
18. Takuma Y., Nouso K., Makino Y., Saito S., Takayama H., Takahara M., et al. Hepatic steatosis correlates with the postoperative recurrence of hepatitis C virus-associated hepatocellular carcinoma. Liver Int 27 (2007) 620-626
19. Anstee Q.M., and Goldin R.D. Mouse models in non-alcoholic fatty liver disease and steatohepatitis research. Int J Exp Pathol 87 (2006) 1-16
20. Newell P., Villanueva A., Friedman S.L., Koike K., and Llovet J.M. Experimental models of hepatocellular carcinoma. J Hepatol 48 (2008) 858-879
21. Horie Y., Suzuki A., Kataoka E., Sasaki T., Hamada K., Sasaki J., et al. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinoma. JCI 113 (2004) 1774-1783
22. Watanaba S., Horie Y., and Suzuki A. Hepatocyte-specific Pten deficient mice as a novel model for nonalcoholic steatohepatitis and hepatocellular carcinoma. Hepatol Res 33 (2005) 161-166
23. Sato W., Horie Y., Kataoka E., Ohshima S., Dohmen T., Iizuka M., et al. Hepatic gene expression in hepatocyte-specific Pten deficient mice showing steatohepatitis without ethanol challenge. Hepatol Res 34 (2006) 256-265
24. Gans J.H. Diethylnitrosamine-induced changes in mouse liver morphology and function. Proc Soc Exp Biol Med 53 (1976) 116-120
25. Travis C.C., McClain T.W., and Birkner P.D. Diethylnitrosamine-induced hepatocarcinogenesis in rats: a theoretical study. Toxicol Appl Pharmacol 109 (1991) 289-304
26. He X.Y., Smith G.J., Enno A., and Nicholson R.C. Short-term diethylnitrosamine-induced oval cell responses in three strains of mice. Pathology 26 (1994) 154-160
27. Onishi M., Sokuza Y., Nishikawa T., Mori C., Uwataki K., Honoki K., et al. Different mutation patterns of mitochondrial DNA displacement-loop in hepatocellular carcinomas induced by N-nitrosodiethylamine and a choline-deficient l-amino acid-defined diet in rats. Biochem Biophys Res Commun 362 (2007) 183-187
28. Shimizu K., Onishi M., Sugata E., Sokuza Y., Mori C., Nishikawa T., et al. Disturbance of DNA methylation patterns in the early phase of hepatocarcinogenesis induced by a choline-deficient l-amino acid-defined diet in rats. Cancer Sci 98 (2007) 1318-1322
29. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Nonalcoholic steatohepatitis clinical research network. design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41 (2005) 1313-1321
30. Edmondon H., and Steiner P.E. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7 (1954) 462-503
31. Kojiro M. Advanced hepatocellular carcinoma. Pathology of hepatocellular carcinoma (2006), Blackwell Publishing, Malden, USA 77-96 Chapter 6
32. Oliveira C.P.M.S., Gayotto L.C.C., Tatai C., Della Nina B.I., Janiszewski M., Lima E.S., et al. Oxidative stress in pathogenesis of experimental liver esteatosis in rats fed choline deficient diet. J Cell Mol Med 6 (2002) 399-406
33. Stefano J.T., Oliveira C.P.M.S., Correa-Giannella M.L., Lima V.M.R., Sá S.V., Oliveira E.P., et al. Nonalcoholic steatohepatitis (NASH) in Ob/Ob mice treated with Yo Jyo Hen Shi Ko (YHK): effects on peroxisome proliferator-activated receptors (PPARs) and microsomal triglyceride transfer protein (MTTP). Dig Dis Sci 52 (2007) 3448-3454
34. Oliveira C.P.M.S., Simplicio F.I., Lima V.M.R., Yuahasi K., Lopasso F.P., Alves V.A.F., et al. Oral administration of S-nitroso-n-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats. World J Gastroenterol 12 (2006) 1905-1911
35. Oliveira C.P.M.S., Coelho A.M.M., Barbeiro H.V., Lima V.M.R., Soriano F., Ribeiro C., et al. Liver mitochondrial dysfunction and oxidative stress in the pathogenesis of experimental nonalcoholic fatty liver disease. Braz J Med Biol Res 39 (2006) 1-6
36. De Lima V.M., de Oliveira C.P., Sawada L.Y., Barbeiro H.V., de Mello E.S., Soriano F.G., et al. Yo jyo hen shi ko, a novel Chinese herbal, prevents nonalcoholic steatohepatitis in ob/ob mice fed a high fat or methionine-choline-deficient diet. Liver Int 27 (2007) 227-234
37. Baumgardner J.N., Shankar K., Hennings L., Badger T.M., and Ronis M.J. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. Am J Physiol Gastrointest Liver Physiol 294 (2008) G27-G38
38. Savransky V., Bevans S., Nanayakkara A., Li J., Smith P.L., Torbenson M.S., et al. Chronic intermittent hypoxia causes hepatitis in a mouse model of diet-induced fatty liver. Am J Physiol Gastrointest Liver Physiol 293 (2007) G871-G877
39. Stiles B., Wang Y., Stahl A., Bassilian S., Lee W.P., Kim Y.J., et al. Liver-specific deletion of negative regulator Pten results in fatty liver and insulin hypersensitivity. Proc Natl Acad Sci USA 101 (2004) 2082-2087
40. Li X., Zhou X.P., Guan Y.S., and Wang Y.X. Magnetic resonante imaging of hepatocellular carcionoma induced by diethylnitrosamine in Sprague-Dawley rats. Hepatobiliary Pancreat Dis Int 4 (2005) 427-432
41. Mulcahy L.S., and Gans J.H. The fidelity of mouse liver mitochondrial DNA polymerase following long-term administration of carbon tetrachloride, diethylnitrosamine or phenobarbital. Mol Pharmacol 24 (1983) 329-335
42. Halliwell B., and Gutteridge J.M.C. Protection against oxidants in biological systems: the superoxide theory of oxygen toxicity. In: Cheeseman K.H., and Slater T.F. (Eds). Free radicals in biology and medicine (1989), Clarendon Press, Oxford 44-147
43. Garcea R., Canuto R.A., Biocca M.E., Muzio G., Rossi M.A., and Dianzan M.U. Functional alterations of the endoplasmic reticulum and the detoxification systems during di-ethylnitrosamine carcinogenesis in rat liver. Cell Biochem Funct 2 (1984) 177-181
44. Zhao W.-D., Guan S., Zhou K.-R., Li H., Peng W.-J., Tang F., et al. In vivo detection of metabolic changes by 1H-MRS in the DEN-induced hepatocellular carcinoma in wistar rat. J Cancer Res Clin Onc 131 (2005) 597-602
45. Turlin B., Le Quilleuc D., Leroyer P., Brissot P., Deugnier Y., and Loreal O. High vascular endothelial growth factor (VEGF) expression in chemically-induced hepatic microcancers in mice. J Hepatol 37 (2002) 620-624
46. Fausto N., and Campbell J.S. The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev 120 (2003) 117-130
47. Roskam T.A., Thiese N.D., Balabaud C., Bhagat G., Bhathal P.S., Bioulac-Sage P., et al. Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology 39 (2004) 1739-1745
48. Hsia C.C., Evarts R.P., Nakatsukasa H., Marsden E.R., and Thorgeirsson S.S. Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology 16 (1992) 1327-1333
49. Uenishi T., Kubo S., Yamamoto T., Shuto T., Ogawa M., Tanaka H., et al. Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci 94 (2003) 851-857
50. Van Eyken P., Sciot R., Paterson A., Callea F., Kew M.C., and Desmet V.J. Cytokeratin expression in hepatocellular carcinoma: an immunohistochemical study. Hum Pathol 19 (1988) 562-568
51. Wu P.C., Lai V.C., Fang J.W., Gerber M.A., Lai C.L., and Lau J.Y. Hepatocellular carcinoma expressing both Hepatocellular and biliary markers also expresses cytokeratin 14, a marker of bipotential progenitor cells. J Hepatol 31 (1999) 965-966
52. Durnez A., Verslype C., Nevens F., Fevery J., Aerts R., Pirenne J., et al. The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma.A possible progenitor cell origin. Histopathology 49 (2006) 138-151
53. Ding S.J., Li Y., Tan Y.X., Jiang M.R., Tian B., Liu Y.K., et al. From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics 3 (2004) 73-81
54. Libbrecht L., and Roskam T. Molecular diagnostic approach to liver tissue as an ancillary tool for liver histopathology. Semin Liver Dis 26 (2006) 328-336
55. Lee J.S., Heo J., Libbrecht L., Chu I.S., Kaposi-Novak P., Calvisi D.F., et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 12 (2006) 410-416
56. Theise N.D., and Krause D.S. Toward a new paradigm of cell plasticity. Leukemia 16 (2002) 542-548
57. Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39 (2004) 1477-1487
58. Sell S., Leffert H.L., Shinozuka H., Lombardi B., and Goochman N. Rapid development of large numbers of alpha-fetoprotein-containing 'oval' cells in the liver of rats fed N-2-fluoronylacetamide in a choline-devoid diet. Gann 72 (1981) 479-487
59. Smith P.G., Tee L.B., and Yeoh G.C. Appearance of oval cells in the liver of rats after long-term exposure to ethanol. Hepatology 23 (1996) 145-154
60. Richardson M.M., Jonsson J.R., Powell E.E., Brunt E.M., Neuschwander-Tetri B.A., Bhathal P.S., et al. Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction. Gastroenterology 133 (2007) 80-90
61. Albano E., Mottaran E., Vidali M., Reale E., Saksena S., Occhino G., et al. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut 54 (2005) 987-993
62. Niedernhofer L.J., Daniels J.S., Rouzer C.A., Greene R.E., and Marnett L.J. Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells. J Biol Chem 278 (2003) 31426-31433